Amgen AMGN and Bristol Myers Squibb BMY are among the largest global biotechnology companies with broad and diverse ...

Regeneron's lead counsel was Jonathan D. Polkes of White & Case LLP.

Amgen threatened to withhold rebates unless PBMs preferred Repatha and excluded Praluent ... or pain/tenderness at the injection site; flu or flu-like symptoms; diarrhea; muscle pain; muscle ...

and Sanofi/Regeneron’s Repatha (alirocumab) – but these require subcutaneous injection every two to four weeks. Sales of both the commercially available antibodies have failed to live up to ...

Sanofi and Regeneron have scored a major victory in their fight with Amgen in the market for cardiovascular drugs, after releasing data showing their Praluent injection reduces risk of ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. A federal jury in Delaware ...

The pharmaceutical company claimed Amgen bundled anti-inflammatory drugs Enbrel and Otezla to convince pharmacy benefit managers to select Repatha as the exclusive PCSK9 category product over ...

Amgen threatened to withhold rebates unless PBMs preferred Repatha and excluded Praluent. Amgen prevented Regeneron from competing on a level playing field and unfairly denied patients access to ...

“But, it's exciting to get an injection of youth to go along with a lot of the veterans that we have on this football team. So, it's exciting. It's going to be fun to work with them.” The ...

The This Morning star, 50, admitted she was initially scared of using weight loss injections after learning more about them. She feels that perhaps they are not the right option for her at this ...